Lokelma - (5g, 10g/ packet ; Oral suspension)

Generic Name	Sodium Zirconium Cyclosilicate	Innovator	Astrazeneca
Dosage	5g, 10g/ packet ; Oral suspension	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	LOKELMA is a potassium binder indicated for the treatment of hyperkalemia in adults.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
*****	*** / *********	*** **, ****	*******	****	*** ****** *** ****
*****	*** / *********	*** **, ****	*******	****	******* *** **** *** *** ****
********	*** / *********	*** **, ****	*******	****	*** ****** *** ****

Chronology Of Events